Answers are grounded in this paper and cite their sources.
Treating bone defects remains a clinical challenge due to limitations of autologous and allogeneic grafts. Fabricating materials that accelerate bone defect repair has considerable scientific and clinical value. In this study, multifunctional composite hydrogel microspheres were prepared using microfluidic technology. These microspheres, loaded with magnesium oxide nanoparticles and interleukin-4 (IL-4), enabled sustained magnesium ions (Mg2+) release (up to 42 days) and IL-4 release (up to 28 days), regulating the osteogenic immune microenvironment. The microspheres showed excellent biocompatibility in vitro. Released Mg2+ promoted bone marrow mesenchymal stem cells (BMSCs) osteogenesis and human umbilical vein endothelial cells (HUVECs) angiogenesis, while IL-4 induced M2 macrophage polarization to create a pro-regenerative immune microenvironment. The effects of the microspheres in facilitating bone defect repair were further validated in animal models. Results showed that the microspheres promoted bone regeneration through a triple cooperative effects mechanism. First, the sustained release of Mg2+ directly promoted bone regeneration and vascularization in the defect area; second, the slow release of IL-4 optimized the local osteogenic immune microenvironment; and finally, the structure of the microspheres provided a three-dimensional microenvironment suitable for bone regeneration. This multipurpose platform offers a novel approach for clinical bone defect therapy by combining immunomodulation, ion release, and structural support.
No takes yet. Share an insight, caveat, or question.
Bao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: